MoonLake Immunotherapeutics AG ("MoonLake"), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, announced that it is proceeding with a global...
LogicBio® Therapeutics, Inc. , a clinical-stage genetic medicine company, announced that president and chief executive officer, Frederic Chereau, will present a company overview at...
CELLTREAT® Scientific Products ("CELLTREAT") and VistaLab™ Technologies ("VistaLab") announced the execution of a definitive agreement under which CELLTREAT has agreed to acquire VistaLab. The...
Synergy Biomedical, LLC, a developer of innovative biomaterial products, announced the launching of BIOSPHERE® FLEX SP EXTREMITIES, Synthetic Bioactive Bone Graft. Using Synergy’s proprietary...
Imbria Pharmaceuticals, Inc., a clinical stage, cardio-metabolic company developing novel therapies designed to enhance cellular energetics, announced that Anne Prener, president and chief executive...
